Who Paid My Doc
Lumoxiti
Drug Oncology
NDC 73380-4700-1
General payments
$72,350
Research payments
$363,069
Through program year 2021, $72,350 in general payments and $363,069 in research payments were reported against Lumoxiti (Oncology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | General | $21,712 | 8 |
| 2021 | Research | $150,989 | 20 |
| 2020 | General | $50,638 | 121 |
| 2020 | Research | $212,080 | 2 |
Breakdown
The top 5 of 8 recipients; each share is of general payments naming this product in 2021.
Each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.
The top 5 of 6 states; each share is of general payments naming this product in 2021 where a state was reported.
Records
129 general · 22 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.